Home/Filings/4/0001567619-21-005492
4//SEC Filing

MATTHEWS TERENCE H 4

Accession 0001567619-21-005492

CIK 0001236997other

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 2:03 PM ET

Size

22.9 KB

Accession

0001567619-21-005492

Insider Transaction Report

Form 4
Period: 2021-03-01
MATTHEWS TERENCE H
DirectorChairman10% Owner
Transactions
  • Other

    Common Shares

    2021-03-01$3.49/sh1,649,112$5,755,4010 total(indirect: Wesley Clover International Corporation)
  • Other

    Deferred Share Units

    2021-03-0181,157.20 total
    Common (81,157.2 underlying)
Holdings
  • Deferred Share Units

    From: 2009-12-14Common (4,838.7 underlying)
    4,838.7
  • Deferred Share Units

    From: 2010-06-18Common (3,000 underlying)
    7,838.7
  • Deferred Share Units

    From: 2011-07-25Common (1,621.6 underlying)
    9,460.3
  • Deferred Share Units

    From: 2012-07-19Common (1,539.7 underlying)
    11,000
  • Deferred Share Units

    From: 2013-07-25Common (2,262.5 underlying)
    13,262.5
  • Deferred Share Units

    From: 2014-07-11Common (3,427.4 underlying)
    16,689.9
  • Deferred Share Units

    From: 2015-07-17Common (7,211.3 underlying)
    23,901.2
  • Deferred Share Units

    From: 2016-07-14Common (15,345 underlying)
    39,246.2
  • Deferred Share Units

    From: 2017-07-14Common (16,943 underlying)
    56,189.2
  • Deferred Share Units

    From: 2018-07-26Common (14,459 underlying)
    70,648.2
  • Deferred Share Units

    From: 2020-07-10Common (2,000 underlying)
    81,157.2
  • Common Shares

    (indirect: Wesley Clover International Corporation)
    1,649,112
  • Deferred Share Units

    From: 2019-11-04Common (12,509 underlying)
    83,157.2
Footnotes (3)
  • [F1]Dr. Matthews owns 99.999% of the issued and outstanding voting shares of Wesley Clover International Corporation.
  • [F2]Each deferred share unit is convertible into one common share of CounterPath Corporation at no additional cost. There is no expiry date. The deferred share units vest immediately.
  • [F3]In connection with a merger with a subsidiary of Alianza, Inc., the common shares were acquired for $3.49 per common share and the deferred share units were cancelled in exchange for $3.49 per deferred share unit.

Documents

1 file

Issuer

COUNTERPATH CORP

CIK 0001236997

Entity typeother

Related Parties

1
  • filerCIK 0001220385

Filing Metadata

Form type
4
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 2:03 PM ET
Size
22.9 KB